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Abstract
Objective: To establish individually expandable primary fibroblast and ker-
atinocyte cultures from 3-mm skin punch biopsies for patient-derived in vitro
skin models to investigate of small fiber pathology. Methods: We obtained 6-
mm skin punch biopsies from the calf of two patients with small fiber neuropa-
thy (SFN) and two healthy controls. One half (3 mm) was used for diagnostic
intraepidermal nerve fiber density (IENFD). From the second half, we isolated
and cultured fibroblasts and keratinocytes. Cells were used to generate patient-
derived full-thickness three-dimensional (3D) skin models containing a dermal
and epidermal component. Cells and skin models were characterized morpho-
logically, immunocyto- and -histochemically (vimentin, cytokeratin (CK)-10,
CK 14, ki67, collagen1, and procollagen), and by electrical impedance. Results:
Distal IENFD was reduced in the SFN patients (2 fibers/mm each), while
IENFD was normal in the controls (8 fibers/mm, 7 fibers/mm). Two-dimen-
sional (2D) cultured skin cells showed normal morphology, adequate viability,
and proliferation, and expressed cell-specific markers without relevant differ-
ence between SFN patient and healthy control. Using 2D cultured fibroblasts
and keratinocytes, we obtained subject-derived 3D skin models. Morphology of
the 3D model was analogous to the respective skin biopsy specimens. Both, the
dermal and the epidermal layer carried cell-specific markers and showed a
homogenous expression of extracellular matrix proteins. Interpretation: Our
protocol allows the generation of disease-specific 2D and 3D skin models,
which can be used to investigate the cross-talk between skin cells and sensory
neurons in small fiber pathology.
Introduction
Small fiber neuropathy (SFN) is a subgroup of sensory
neuropathies, which selectively impairs thinly myelinated
A-delta and unmyelinated C nerve fibers and characteris-
tically leads to acral burning pain, par- and dysesthesias.
The peripheral nerve endings of the small fibers terminate
in the epidermis as nociceptors, where they are exposed
to direct influences from the environment, but also from
the surrounding skin cells. It is striking, that intraepider-
mal innervation is reduced in SFN patients, while pain is
a key symptom. Thus, hyperexcitability of the dorsal root
ganglion sensory neurons or the remaining peripheral
nociceptors is assumed. Indeed, we found an increase in
pro-inflammatory cytokine gene expression in skin punch
biopsies of SFN patients that may contribute to nocicep-
tor sensitization.1 Interestingly, this increase was not
based on cutaneous inflammatory cell infiltration, which
raises the question of a potential role of surrounding skin
cells as a source for algesic mediators.
Keratinocytes secrete neuroactive molecules capable of
modulating sensory neurons such as neurotrophins, ade-
nose intriphosphate, and cytokines, and carry nocicep-
tion-associated ion channels, growth factor, and cytokine
receptors.2,3 In a recent study using human two-dimen-
sional (2D) culture models, the interaction of
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keratinocytes and sensory nerve fibers via formation of
sensory units was shown.4 Another study applying opto-
genetics in mice revealed that activation of epidermal ker-
atinocytes elicits action potentials in sensory neurons.5
These studies suggest an active role of keratinocytes in
sensory processing and support the novel concept of cuta-
neous nociception. Furthermore, skin cells release axon
guidance cues like netrins and semaphorins, which may
direct nerve fiber growth.6,7 Thus, evidence is increasing
for a potential pathophysiological role of keratinocytes in
peripheral innervation and sensory neuron sensitization,
and novel experimental approaches are needed for trans-
lational in-depth analysis of the underlying mechanisms,
which is hampered by the limited availability of human
biomaterial.
A promising tool to study interactions between periph-
eral nociceptors and skin cells is three-dimensional (3D)
full-thickness skin model (FTSM).8 FTSM enables the
investigation of human cell–cell and cell–matrix interac-
tions which is particularly useful when suitable animal
models are lacking. However, published protocols require
large biopsies of several cm2 area,9 highly proliferative
juvenile cells,10 or a combination of both, and are there-
fore not applicable when only few millimeter skin samples
of adult patients are available as obtained for routine
diagnostics. Our aim was to establish individually expand-
able primary keratinocyte and fibroblast 2D and 3D cell
culture models from 3-mm skin punch biopsies and to
generate patient-derived FTSM as a new in vitro tool for
the investigation of the pathophysiological impact of skin
cells on small fiber pathology.
Methods
Patient recruitment
Patients with SFN were prospectively recruited at the
Department of Neurology, University of W€urzburg, Ger-
many, according to current criteria11 and after exclusion
of large fiber polyneuropathy using clinical examination
and nerve conduction studies. Additionally, age- and sex-
matched healthy controls were recruited. For the estab-
lishment of subject-derived skin models, skin punch biop-
sies were obtained from two patients with SFN and two
healthy controls (Table 1).
Isolation of adult skin cells
Skin punch biopsy
Figure 1 depicts our experimental setup. A 6-mm skin
punch biopsy (apparatus by Stiefel GmbH, Offenbach,
Germany) was taken in local anesthesia from the calf
10 cm above the lateral malleolus of two patients with
idiopathic SFN and two healthy controls following a stan-
dard procedure.1 Each skin sample was divided in two 3-
mm parts: one part was used for immunohistochemical
determination of the intraepidermal nerve fiber density
(IENFD) as practiced in clinical routine12; the second part
was processed for the isolation of adult human dermal
fibroblasts (hDF) and epidermal keratinocytes (hEK). The
epidermis was manually separated from the dermis using
a scalpel (B. Braun, Melsungen, Germany). Both halves
were further processed for primary cell cultures of hDF
and hEK immediately after partitioning.
hDF culture
To obtain hDF, the dermis was cut into three small pieces
placed in a T25 flask which were covered with 10 µL of
Dulbecco‘s Modified Eagle Medium, F-12 Nutrient Mix-
ture (DMEM/F-12) with 1% penicillin/streptomycin, and
with 10% fetal calf serum (fibroblast medium, Thermo
Fischer Scientific, Carlsbad, USA), and incubated for 1h
at 37°C, 5% CO2 to ensure cell attachment. Thereafter,
1.5-mL fibroblast medium was carefully added. Medium
was changed every 2–3 days until cell outgrowth was
observed. Subsequently, cells were expanded and further
processed at passage four.
hEK culture
For the extraction of hEK, the epidermis was cut into
nine small pieces and placed into three T25 cell culture
bottles (three pieces per bottle) with the basal layer facing
down toward the cell culture surface. To ensure cell
attachment, samples were covered with 10 µL of fibrob-
last medium and incubated for 1 h at 37°C, 5% CO2.
Table 1. Patient characteristics.
SFN-1 SFN-2 Ctr-1 Ctr-2
Sex Male Male Male Male
Age 54 44 69 29
SFN etiology Idiopathic Idiopathic N/A N/A
Current pain intensity
(on numeric
rating scale 0–10)
8/10 4/10 N/A N/A
Pain localization
and character
Acral burning Acral burning N/A N/A
pain attacks Yes Yes N/A N/A
Pain duration 6 years 6 years N/A N/A
IENFD at calf
(fibers/mm)
2 2 7 8
Abbreviations: Ctr, control; IENFD, intraepidermal nerve fiber density;
N/A, not applicable; SFN, small fiber neuropathy.
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Thereafter, 1.5-mL fibroblast medium was carefully
added. Cells were inspected daily until keratinocyte out-
growth was observed. Then, medium was changed to ker-
atinocyte medium (EpiLife Medium supplemented with
1% Epilife defined growth supplement, and 1% penicillin/
streptomycin, Thermo Fischer Scientific, Carlsbad, USA).
After passage two, magnetic-activated cell sorting (MACS)
with human Anti-Fibroblast MicroBeads (Miltenyi Biotec
GmbH, Bergisch Gladbach, Germany) was used according
to the manufacturer’s protocol for purification of the
hEK primary cell culture. Medium was changed every 2–
3 days. Cells were further processed at passage four.
Cellular impedance
Measurements of cellular real-time impedance for hEK
and hDF were performed with xCELLigence RTCA DP
(Roche, Basel, Switzerland). About 3000 cells/well (n = 3/
cell type) were seeded in 200 µL of the respective med-
ium into an E-plate 96 (ACEA Biosciences Inc., San
Diego; USA). Cell-based impedance (as reflected by the
cell index) was measured hourly in a time interval of 50–
100 h after cell seeding. Cellular doubling time (i.e. per-
iod of time that is needed for doubling a cell population)
was calculated from the obtained data by fitting the curve
to an exponential equation. Each cell line was measured
in triplicate and RTCA Data Analysis Software 1.0
(Roche, Basel, Switzerland) was used for analysis. Data
are illustrated as line charts or bar graphs (GraphPad
Prism 7 software, San Diego, USA), representing the
mean and standard deviation.
Generation of FTSE
Full-thickness skin equivalents (FTSE) were generated
using a Corning Costar well plate. First, hDF
(4.5 9 104 cells) were embedded in collagen I hydrogel
isolated in-house from rat tails to build the dermal layer
of the FTSE. Care was taken to avoid the formation of air
bubbles in the highly viscous collagen I hydrogel. The
dermal layer was cultivated in Epilife medium supple-
mented with 1X human keratinocyte growth supplement
Figure 1. Experimental setup. 6-mm skin punch biopsies were taken from the patients with small fiber neuropathy and the healthy controls and
were divided into two 3-mm parts each. One half was used for intraepidermal nerve fiber density (IENFD) assessment with specific antibodies
against protein gene product-9.5. In the second half, the epidermis was separated manually from the dermis. Both parts were then cut into small
pieces and placed into cell culture flasks. Magnetic-activated cell sorting (MACS) was used to purify the initially mixed skin cell culture and to gain
human epidermal keratinocytes (hEK) for epidermis formation. Human dermal fibroblasts (hDF) were used to build a dermal layer. hEK were
seeded on top of the dermal layer to generate a full-thickness skin equivalents (FTSE).
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(both Thermo Fisher Scientific, Waltham, MA USA),
100 U/mL penicillin-streptomycin, 1.5-mmol/L CaCl2
(both Sigma-Aldrich, St. Louis, USA), 10 ng/mL ker-
atinocyte growth factor, and 73 lg/mL L-ascorbic acid 2-
phosphate (both Sigma-Aldrich, St. Louis, USA). Medium
was changed every 2–3 days.
After 1 week of culture, hEK were seeded on the der-
mal layer (5 9 105 cells). Medium was removed from the
epidermal layer after 24 h. At the air–liquid interface,
hEK formed an epidermis with vital cell layers and a stra-
tum corneum. FTSE were cultured for 14 days. Medium
was changed every 2–3 days.
Immunocytochemistry and
immunohistochemistry
For immunocytochemistry, cells were fixed with 50%
ethanol, 50% acetone mixture for 10 min at room tem-
perature. FTSE and native skin for immunohistochemistry
were fixed with Roti-Histofix 4% (Carl Roth, Karlsruhe,
Germany) for 1 h room temperature, washed in tap water
for 1 h, and embedded in paraffin. Afterwards, 4-µm his-
tological cross sections were prepared using a microtome
SM 2010 R (Leica, Wetzlar, Germany). For morphological
assessment, skin sections were stained with hematoxylin
and eosin (HE). Immunoreactions with antibodies against
the intermediate filament of epithelial cells cytokeratin
(CK)-10 (DAKO Cytomation, Hamburg, Germany,
1:100), the marker for basal keratinocytes CK-14 (Sigma-
Aldrich, St. Louis, USA, 1:1000), nuclear proliferation
marker ki67 (Abcam, Cambridge, UK 1:100), the interme-
diate filament of mesenchymal cells vimentin (Abcam,
Cambridge, UK, 1:2000), the structural protein collagen 1
(Acris Antibodies, Herford, Germany, 1:100), and the col-
lagen precursor procollagen (Merck Millipore, Burlington,
USA 1:200) were performed. Briefly, paraffin-embedded
skin sections were deparaffinized, rehydrated, and rinsed
in demineralized water. Slides were incubated at +4°C
over night with the primary antibodies. Donkey anti-
mouse IgG (Life Technologies, Carlsbad, USA, 1:400),
donkey anti-rabbit IgG (Life Technologies, Carlsbad,
USA, 1:400), or goat anti-rat IgG (Life Technologies,
Carlsbad, USA, 1:200) were used as secondary antibodies.
For IENFD determination, skin sections were embedded
in Tissue Tek, OCT medium (optimal cutting tempera-
ture; Sakura, Staufen, Germany) and frozen in 2-
methylbutane cooled in liquid nitrogen. Forty micrometer
cryosections were prepared using a cryostat (Leica, Blen-
heim, Germany). Sections were immunoreacted with anti-
bodies against the panaxonal marker protein gene
product 9.5 (PGP 9.5; Zytomed, Berlin, Germany, 1:
1000). As secondary antibody, goat anti-rabbit IgG
(Amersham, Kingsport, TN, 1:100) was applied. Positive
nerve fibers were quantified using a fluorescent micro-
scope (Axiophot 2, Zeiss, Oberkochen, Germany) by two
investigators blinded to the diagnosis.
Results
Patient characteristics
Details about demographic and clinical data of two
patients with SFN (SFN-1, and SFN-2) and two healthy
controls (Ctr-1, and Ctr-2) are given in Table 1. The SFN
diagnosis was made according to current criteria and after
exclusion of large fiber polyneuropathy using clinical
examination and nerve conduction studies.11 The control
subjects showed no symptoms or signs of neuropathy.
Both patients with SFN had reduced IENFD, while
IENFD at the lower leg was normal in healthy controls
(SFN-1, Ctr-2; Fig. 2).
Primary fibroblasts and keratinocyte 2D cell
culture
We succeeded in isolating hDF and hEK cells from the 3-
mm skin specimens of the SFN patient (SFN-1) and the
healthy control (Ctr-2), and established stable hDF
(Fig. 3)A and B and hEK (Fig. 3C and D) cell cultures for
subsequent application in FTSM. Morphological assess-
ment showed a typical spindle-shape appearance of the
hDF, whereas hEK displayed a cobblestone morphology.
For cellular characterization, immunoreactions with cell-
specific markers were performed. hDF of the SFN patient
and the healthy control showed homogeneous expression
of the intermediate filament of mesenchymal cells vimen-
tin (Fig. 4A and E). hEK isolated from the SFN patient
and the healthy control expressed the basal epidermal
marker CK-14 in 2D cell culture but were negative for
the intermediate filament of differentiated keratinocytes
CK-10 (Fig. 4B, C, F, and G). The nuclear proliferation
marker ki67 was equally expressed in hEK of the SFN
patient and the healthy control (Fig. 4D and H). We did
not detect morphological or immunocytochemical differ-
ences between skin cells obtained from the SFN patient
and the healthy control.
Adequate cellular viability and constant
proliferation of the SFN patient and the
healthy control
To assess the viability and proliferation of skin cells in 2D
culture, real-time impedance was determined in hEK and
hDF of the patient (SFN-1) and the healthy control (Ctr-2).
The cell index of both cell types constantly increased indi-
cating adequate viability and constant proliferation without
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Figure 2. Representative photomicrographs of skin biopsy sections immunoreacted with antibodies against protein gene product-9.5 for the
detection of intraepidermal nerve fibers (IENF). IENF (indicated by white arrows) were reduced in the skin sample obtained from the lateral calf of
a patient with small fiber neuropathy (SFN-1, A) compared to a healthy control (Ctr-2, B). Scale bar represents 100 lm.
Figure 3. 2D culture of primary human dermal fibroblasts (hDF) and epidermal keratinocytes (hEK). Phase contrast images of hDF culture of a
patient (SFN-1) with small fiber neuropathy (SFN, A), a healthy control (Ctr-2, B), and hEK culture of a patient with SFN (C) and a healthy control
(D). The morphology was normal in the hDF and hEK of the SFN patient and the healthy control. Scale bar represents 100 lm.
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relevant difference between the SFN patient and the healthy
control (Fig. 5A and B). In contrast, the doubling time of
hDF and hEK obtained from the SFN patient was lower
(Fig. 5C, hDF: 217.47 h; hEK: 96.27 h) compared to those
from the healthy control (hDF: 89.11 h; hEK: 57.65 h).
Characterization of the FTSM
After 3 weeks, a FTSM was generated in skin cells
obtained from two SFN patients (Fig. 6A, B) and two
healthy controls (Fig. 6C, D). We first used HE
CK14 CK10 ki67
Ct
r
SF
N
Figure 4. Expression of cell-specific markers in fibroblasts and keratinocytes. Skin cells of a patient (SFN-1) with small fiber neuropathy (SFN, A–
D) and a healthy control (Ctr-2, E–H) were immunoreacted with specific antibodies against vimentin (A, E), cytokeratin (CK)-14, CK-10, and ki67.
Human dermal fibroblasts (hDF) expressed vimentin (A, E), whereas human epidermal keratinocytes (hEK) expressed the epithelial marker CK-14
(B, F), but not CK-10 (C, G). hEK also expressed the nuclear proliferation marker ki67 (D, H). Scale bar represents 50 lm.
Figure 5. Real-time impedance measurements using xCELLigence instrument. Line charts display the cell index within the time frame of 50–
100 h after seeding human dermal fibroblasts (hDF, A) and human epidermal keratinocytes (hEK, B) of the patient with small fiber neuropathy
(SFN-1) and the healthy control (Ctr-2). Both cell types showed increase in the cell index, without differences between the cells of the SFN patient
and the healthy control. Bar graphs show the doubling time (C) of hDF and hEK isolated from the patient with SFN and the healthy control. The
doubling time of both cell types from the patient with SFN was lower compared to the healthy control.
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Figure 6. Morphological structure of the full-thickness skin model (FTSM). Macroscopic images of the FTSM of two patients with small fiber
neuropathy (SFN, A, B) and two healthy controls (Ctr, C, D). Hematoxylin and eosin (HE) stainings of the FTSM (A0-D0), the respective skin punch
biopsy (A″–D″) of the patients with SFN, and the healthy control. Morphology was normal in the FTSM of the SFN patients and the healthy
controls, and was similar to that of native skin. Scale bar represents 100 lm.
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staining to assess the morphological structure of the
FTSM. The overall morphology of the FTSM was anal-
ogous to the respective HE stains performed on skin
punch biopsy sections both in the SFN patients
(Fig. 6A0 and A″; 6B0 and B″) and the healthy controls
(Fig. 6C0 and C″; 6D0 and D″) consisting of a dermis
and a multilayered epidermis with stratum corneum.
To further investigate the composition of the FTSM of
one patient with SFN (SFN-1) and one healthy control
(Ctr-2), we performed immunoreactions with antibodies
against selected tissue-specific markers. Both models
expressed intermediate filament markers, CK-10 and
CK-14, in the epidermal layer. Differentiation between
the basal and suprabasal strata of the epidermis was
not possible in both models due to the low number of
epidermal layers. The dermal layer showed a homoge-
neous distribution of vimentin, collagen 1, and procol-
lagen (Fig. 7). We did not detect morphological or
immunohistochemical differences between the FTSM of
the SFN patient and the healthy control. We also per-
formed immunoreactions on native skin from a healthy
control subject embedded in paraffin (Ctr.2; Fig. 7).
Expression of the markers CK-10, CK-14, vimentin, col-
lagen 1, and procollagen was similar to the FTSM.
Discussion
We set out to individually isolate and expand hDF and
hEK cell cultures and provide a protocol to isolate both
cell types from a single 3-mm skin punch biopsy obtained
from adult subjects. We have succeeded in generating 2D
cell cultures and a 3D in vitro skin model from individual
subject-derived cells which can now be used for in-depth
pathophysiological analysis of small fiber damage. We
showed that both cell types have the typical morphology,
express cell-specific markers, and display constant prolif-
eration as determined by impedance measurement.
SFN is a subgroup of sensory neuropathies, which is
characterized by burning pain and dysesthesias in hands
and feet, while skin punch biopsies typically reveal a
reduction in IENFD.11 The traditional view, that neurode-
generative processes in DRG sensory neurons may under-
lie SFN pain and peripheral denervation, is increasingly
challenged by studies providing evidence for an active role
of skin cells in sensory processing and cutaneous nocicep-
tion. As the main skin cell population, keratinocytes and
fibroblasts are in close and active contact with sensory
nerve fiber endings, and human and experimental data
are pointing toward an intensive interaction between skin
Ct
r
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N
procollagencollagen1CK10 CK14
Ct
r
FTSM
Figure 7. Cellular composition of the full-thickness skin model (FTSM) and native skin. FTSM of a patient (SFN-1) with small fiber neuropathy
(SFN, A–E), FTSM and native skin of a healthy control (Ctr-2, F–J and K–O) were immunoreacted with antibodies against cytokeratin (CK)-10, CK-
14, vimentin, collagen 1, and procollagen. CK-10 (A, F, K), and CK-14 (B, G, L) are expressed in the epidermal layer. Both FTSM express vimentin
(C, H, M), collagen 1 (D, I, N), and procollagen (E, J, O) in the dermal layer. Native skin sections contain blood vessels in the dermis (indicated by
arrows). The dotted line marks the epidermis-dermis border. Scale bar represents 100 lm.
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cells and nociceptors.13 This novel concept of skin cell
involvement in sensory signaling is supported by the
expression of nociception-associated receptors14–16 and
the release of pain-related mediators17–19 by fibroblasts
and keratinocytes. In addition, keratinocytes release axon
guidance cues like netrins and semaphorins,6,7 which may
act as local pathfinders.
Several studies have shown the interplay between skin
cells and sensory neurons. Overexpression of neu-
rotrophins like nerve growth factor or neurotrophin 3 by
keratinocytes prolonged neuronal survival.20 Axonal out-
growth was strongly stimulated when cocultivating neu-
rons with keratinocytes, but was absent in pure neuronal
cultures indicating the influence of a potential soluble fac-
tor secreted by keratinocytes.21 Using mice expressing
channelrhodopsin in keratinocytes, a recent study revealed
that mere activation of the epidermis already evokes
action potentials in sensory neurons.5 In transgenic mice,
selective transient receptor potential vanilloid (TRPV) 3
overexpression and heat activation of keratinocytes
induced prostaglandin E2 release causing nocifensive
behavior.22 After conditioned expression of the capsaicin
receptor TRPV1 in keratinocytes of TRPV1-knockout
mice, exclusive stimulation of keratinocytes was sufficient
to evoke pain behavior.23
While data from experimental studies are encouraging,
the limited availability of patient biomaterial remains the
main translational roadblock to transfer knowledge from
bench to bedside. To overcome this hurdle, 3D skin mod-
els have been established. One group developed a hybrid
model of human skin with axonal growth of rat DRG
neurites into the dermis.24 In another study, the authors
developed a skin model using neonatal foreskin fibroblasts
and keratinocytes, coated with human-induced neural
stem cells.25 Recently, a fully human-derived and inner-
vated skin model using fibroblasts and keratinocytes from
breast reductive surgeries was developed.26 The major
drawbacks for the methodological transfer into clinical
studies are the need of large skin samples, juvenile and
highly proliferative cells as prerequisites,9,25 or hybrid
models obtained from different species,27 which are either
not practicable in clinical routine or does not reflect real-
life conditions. Moreover, these tools do not model dis-
ease conditions since skin cells and neurons derived from
healthy donors were included. Here, we established a pro-
tocol, which enables the expansion of patient-derived skin
cells under 2D and 3D conditions using only few millime-
ter of skin from adult subjects obtained under conditions
used in clinical practice.
Our study has some limitations. Although keratinocytes
and fibroblasts are the most abundant cell types in the skin,
various other cells (e.g. immune cells and Schwann cells)
were not included in the current model. Also, cutaneous
structures, such as blood vessels and nerve fibers, are miss-
ing. Future developments improving and extending 2D and
3D cell culture protocols will help refining our model.
Our protocol provides a promising in vitro method for
generating disease-specific 2D cultures and 3D skin mod-
els from a single 3-mm skin punch biopsy. 2D cultures
enable gene expression analysis of distinct skin cells rather
than using the entire skin samples. Likewise, our patient-
derived 3D skin models facilitate individualized in-depth
analysis of cutaneous cell–cell interactions as a potential
contributor to small fiber pathology. Our method also
provides a solid basis for future developments toward
innervated 3D-skin models serving as novel tools in per-
sonalized medicine.
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